MCC950通过NLRP3炎症体和ERK通路的双调节缓解脂肪栓塞诱导的急性呼吸困难综合征

Chin-Kuo Lin1,2, Zheng-Wei Chen3, Yu-Hao Lin3

  • 1Division of Pulmonary Infection and Critical Care, Department of Pulmonary and Critical Care Medicine, Chang Gung Memorial Hospital, Chiayi 20401, Taiwan.

概括

脂肪栓塞通过激活NLRP3炎症体引发急性呼吸困扰综合征 (ARDS). 使用MCC950抑制NLRP3减少了炎症和肺损伤,提供了潜在的ARDS疗法.